Search research articles
Contact Us
Filters
Showing results (161-170 of 301) with videos related to
Page
of 31
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 25, 2022
Toward comprehensive value assessment for Alzheimer's disease innovations
Phyllis B Ferrell, Howard Fillit, Peter J Neumann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 9, 2017
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease
Pei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence
Yue Zhong, Pei-Jung Lin, Joshua T Cohen, et al.
Health Affairs Scholar
|
April 22, 2026
Cost-effectiveness thresholds used in the United States vs most favored nations
Hanxuan Yu, Peter J Neumann, David D Kim, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 3, 2005
Quality of abstracts of papers reporting original cost-effectiveness analyses
Allison B Rosen, Dan Greenberg, Patricia W Stone, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology
Natalia Olchanski, Yue Zhong, Joshua T Cohen, et al.
Journal of the American College of Radiology : JACR
|
December 3, 2019
Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far
Hansel J Otero, Andrew J Degnan, Nadja Kadom, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 20, 2010
How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments
Michael A Kozminski, Peter J Neumann, Eric S Nadler, et al.
International Journal of Technology Assessment in Health Care
|
April 29, 2020
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
Xue Feng, David D Kim, Joshua T Cohen, et al.
Medical Care
|
September 10, 2002
Economic messages in prescription drug advertisements in medical journals
Peter J Neumann, Kara Zivin Bambauer, Vijay Ramakrishnan, et al.
Page
of 31
Search research articles
Search
Showing results (161-170 of 301) with videos related to
Sort By:
Page
of 31
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 25, 2022
Toward comprehensive value assessment for Alzheimer's disease innovations
Phyllis B Ferrell, Howard Fillit, Peter J Neumann, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 9, 2017
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease
Pei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 17, 2015
Cost-utility analyses in diabetes: a systematic review and implications from real-world evidence
Yue Zhong, Pei-Jung Lin, Joshua T Cohen, et al.
Health Affairs Scholar
|
April 22, 2026
Cost-effectiveness thresholds used in the United States vs most favored nations
Hanxuan Yu, Peter J Neumann, David D Kim, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
August 3, 2005
Quality of abstracts of papers reporting original cost-effectiveness analyses
Allison B Rosen, Dan Greenberg, Patricia W Stone, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology
Natalia Olchanski, Yue Zhong, Joshua T Cohen, et al.
Journal of the American College of Radiology : JACR
|
December 3, 2019
Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far
Hansel J Otero, Andrew J Degnan, Nadja Kadom, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
November 20, 2010
How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments
Michael A Kozminski, Peter J Neumann, Eric S Nadler, et al.
International Journal of Technology Assessment in Health Care
|
April 29, 2020
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
Xue Feng, David D Kim, Joshua T Cohen, et al.
Medical Care
|
September 10, 2002
Economic messages in prescription drug advertisements in medical journals
Peter J Neumann, Kara Zivin Bambauer, Vijay Ramakrishnan, et al.
Page
of 31